Gefitinib shows promise in NSCLC
- 4 Downloads
KeywordsEpidermal Growth Factor Receptor Gefitinib Ideal Study Iressa Median Survival Duration
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
© Adis International Ltd 2002